Position in ZVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,553,823
+$1,266,538 QoQ
Shares Held
1,561,569
+5.3% QoQ
Ownership
2.64%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. ZVRA ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ZVRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,553,823 | 1,561,569 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,287,285 | 1,482,956 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,573,537 | 1,427,291 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,939,006 | 1,241,658 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,812,344 | 1,176,548 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,779,117 | 1,172,556 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,363,405 | 772,825 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,527,309 | 719,859 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,962,397 | 683,172 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,166,193 | 636,060 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,028,054 | 628,227 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,031,506 | 594,413 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $605,220 | 110,040 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $471,117 | 102,640 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $640,473 | 102,640 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $457,774 | 102,640 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,774,623 | 551,615 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,693,096 | 538,817 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,099,302 | 546,549 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,330,618 | 493,808 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||